Pathbreaking Advances in Nanomedicine in Ovarcoming Ovarian Cancer

from Connect Ovar Coffee · host OVARCOME

In this episode of Connect Ovar Coffee, Dr. Daniel Heller, Head of Cancer Nanomedicine Lab at Memorial Sloan Kettering Cancer Center joins us to Talk About The Promise of Pathbreaking Advances in Ovarian Cancer With Nanomedicine. Listen. Learn. Share. Let's #ConnectOvarCoffee!

Episode metadata supplied by the publisher feed · Published Jun 2, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Pathbreaking Advances in Nanomedicine in Ovarcoming Ovarian Cancer

0:00 1:02:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Connect Ovar Coffee?

This episode is 1 hour and 2 minutes long.

When was this Connect Ovar Coffee episode published?

This episode was published on June 2, 2024.

Can I download this Connect Ovar Coffee episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!